Purchases and Sales Made in Q2 2022 in Avadel Pharmaceuticals PLC (AVDL)
This table provides information about the institutional ownership of Avadel Pharmaceuticals PLC (AVDL) during Q2 2022. The information is specifically focused on institutions that hold shares of AVADEL PHARMACEUTICALS PLC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 03, 2022
Q2 2022
|
Janney Montgomery Scott LLC
|
SELL
|
- |
-15.5KClosed |
$16.6K - $108K
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Worth Venture Partners, LLC
Fort Lee, NJ |
SELL
|
- |
-15.9KClosed |
$17K - $111K
|
0
$0
|
|
|
Aug 12, 2022
Q2 2022
|
Kestra Advisory Services, LLC
|
SELL
|
- |
-16.2K- 34.69% |
$17.3K - $112K
|
30.4K
$330K
|
|
|
Aug 15, 2022
Q2 2022
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-17K- 13.17% |
$18.2K - $118K
|
112K
$1.21M
|
|
|
Aug 15, 2022
Q2 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-24.1K- 53.73% |
$25.8K - $168K
|
20.8K
$225K
|
|
|
Aug 15, 2022
Q2 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-26.6K- 7.77% |
$28.5K - $185K
|
316K
$3.43M
|
|
|
Oct 27, 2022
Q2 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-26.6K- 7.77% |
$28.5K - $185K
|
316K
$3.43M
|
|
|
Aug 15, 2022
Q2 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-33.8K- 16.44% |
$36.2K - $235K
|
172K
$1.86M
|
|
|
Aug 16, 2022
Q2 2022
|
International Biotechnology Trust PLC
London, X0 |
SELL
|
- |
-49.9K- 99.76% |
$53.4K - $347K
|
122
$1.32K
|
|
|
Aug 15, 2022
Q2 2022
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
- |
-61.6KClosed |
$65.9K - $428K
|
0
$0
|
|
|
Aug 11, 2022
Q2 2022
|
Group One Trading, L.P.
Chicago, IL |
SELL
|
- |
-62.4KClosed |
$66.8K - $434K
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-82K- 88.1% |
$87.8K - $570K
|
11.1K
$120K
|
|
|
Aug 15, 2022
Q2 2022
|
Graham Capital Management, L.P.
Rowayton, CT |
SELL
|
- |
-82.2KClosed |
$87.9K - $571K
|
0
$0
|
|
|
Aug 12, 2022
Q2 2022
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-163K- 68.66% |
$174K - $1.13M
|
74.4K
$806K
|
|
|
Aug 15, 2022
Q2 2022
|
Laurion Capital Management LP
New York, NY |
SELL
|
- |
-182KClosed |
$195K - $1.26M
|
0
$0
|
|
|
Aug 11, 2022
Q2 2022
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-218K- 63.6% |
$234K - $1.52M
|
125K
$1.36M
|
|
|
Aug 15, 2022
Q2 2022
|
Polar Capital Holdings PLC
London, X0 |
SELL
|
- |
-387K- 12.09% |
$414K - $2.69M
|
2.81M
$30.5M
|
|
|
May 14, 2024
Q2 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-466K- 95.73% |
$499K - $3.24M
|
20.8K
$225K
|
|
|
Aug 15, 2022
Q2 2022
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-531K- 25.08% |
$568K - $3.69M
|
1.59M
$17.2M
|
|
|
Aug 15, 2022
Q2 2022
|
Acuta Capital Partners, LLC
Belmont, CA |
SELL
|
- |
-580KClosed |
$621K - $4.03M
|
0
$0
|
|
|
Aug 10, 2022
Q2 2022
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
SELL
|
- |
-952KClosed |
$1.02M - $6.62M
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-1.41MClosed |
$1.51M - $9.8M
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Avoro Capital Advisors LLC
New York, NY |
SELL
|
- |
-1.67MClosed |
$1.79M - $11.6M
|
0
$0
|